DEA Considering Regulation of Telepharmacy Practice

Advanced notice of proposed rulemaking from the Drug Enforcement Administration (DEA) seeks to obtain further information regarding the practice of telepharmacy, which is not specifically defined by the Controlled Substances Act (CSA) or DEA regulations. DEA is considering implementing regulations regarding telepharmacy and seeks to be fully informed about the practice, industry and state regulations.

Comments are due by Jan. 18, 2022.